Published by Josh White on 28th July 2025
(Sharecast News) - Oxford Biomedica reported a sharp rise in first-half revenue and strong commercial momentum on Monday, as it reiterated its full-year guidance and pointed to growing demand across its cell and gene therapy manufacturing platforms.
URL: http://www.digitallook.com/dl/news/story/35244975/...